-
Rahm reaches separation deal with LIV in bankruptcy court
-
ATP proposes rankings system changes, extra player bonuses
-
UN chief urges nations to end 'war on nature'
-
Russell Brand was 'monster-like', alleged victim tells UK court
-
Newcastle boss Jaissle says Fernandez-Pardo just needs a goal
-
Crowded Launches Crowded MCP, Bringing Nonprofit Financial Operations Into ChatGPT and Claude
-
Infantino offers apology but 'no answers' at FIFA meeting over World Cup plan
-
Albanian PM condemns 'chaos' as violent unrest spreads
-
Don't exclude Turkey from 'Made in Europe' plan: minister to AFP
-
Italian football suffers new blow with Champions League misery
-
French duo Justice to score 'GTA VI': game maker
-
Trump scraps plan to livestream execution after broad backlash
-
El Nino a 'terrifying' threat to coral reefs: UN biodiversity expert
-
Seven missing off Romania after latest Black Sea drone attacks
-
Barcola must get used to Liverpool highs and lows, says Iraola
-
ARKBRIDGE Outlines Jonathan Morelli’s “Picks and Shovels” AI Infrastructure Investment Strategy
-
Versus Trade Wins Best ECN/STP Broker APAC 2026, Marking Third UF Awards Recognition
-
Tech sell-off rolls on as hot inflation data stokes rate worries
-
Three dead as Istanbul sees heaviest rainfall in 80 years
-
McIlroy makes 'solid' start in rain-hit Delhi as Norgaard leads
-
US producer prices see biggest jump since 2022 in added challenge to Trump
-
Seven missing after fire on vessel in Black Sea off Romania
-
Swiatek avoids seed exodus to breeze into Wuhan last eight
-
'Severe drought' declared in parts of UK
-
PM condemns 'chaos' as violent protests grip Albania
-
IUX Announces New Web Client Portal Built for Enhanced Browser-Based Trading
-
'I couldn't breathe', Russell Brand's alleged rape victim says
-
School roof collapse kills teacher, 32 children in NW Pakistan
-
Pope's cancer operation already reshaping papacy
-
Inter skipper Martinez facing month out with thigh injury
-
Zverev cruises past De Minaur to reach Shanghai semi-finals
-
Spanish prosecutors back abuse probe into Julio Iglesias
-
Ukraine's Zelensky defies Trump with Russian refinery strikes
-
Tech sell-off deepens as US inflation sparks AI jitters
-
Holders Australia edge New Zealand 24-22 to open Rugby league World Cup
-
Southgate does not forsee a return to management
-
'Ocarina of Time': Nintendo gives Zelda classic a modern makeover
-
Two dead as Istanbul endures heaviest rainfall in 80 years
-
France charges teen shooter citing revenge for bullying in school
-
After latest Nepal flood, survivors fear for future
-
Martinez blames 'anger' for dig at Man Utd hierarchy
-
EU leaders clash over budget as spectre of French elections looms
-
Crowds build as Albanian PM tours protest aftermath
-
'No place to breathe': life in Indonesia's fire epicentre
-
China-North Korea bridge opens, 12 years late
-
'Can't sleep': Spain's housing crunch upends lives
-
Asian Cup in Saudi Arabia could be postponed but 'no hurry' to decide: AFC
-
Musk calls on Ukraine's Zelensky to 'go' after satellite slowdown row
-
Conrad wields axe after South Africa loss to Australia
-
Still smiling at 117, Albanian may be world's oldest woman
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
A.AlHaj--SF-PST